Isotopia USA develops radiopharmaceuticals for cancer care, pairing diagnostic imaging with targeted radiation therapy. Its products include Tb-161 and Lu-177 therapeutics, Isoportrace PSMA-11 for prostate imaging, PET/SPECT radiopharmacy products, and sterile lyophilized offerings plus CMO services. The science works by using radiopharmaceuticals that deliver radiation to tumors while imaging agents locate disease. It differentiates through a global, integrated supply chain with Lu-177 production in Israel and FDA-compliant production in the US to ensure quality and reliable supply; its goal is to improve diagnostic accuracy and treatment outcomes worldwide.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Alton, Illinois
Founded
2007
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?